STAGE III SINONASAL CANCER AJCC V8
Clinical trials for STAGE III SINONASAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III SINONASAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III SINONASAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink hard-to-treat sinus cancers before surgery
Disease control Recruiting nowThis study is for people with a type of sinus cancer called sinonasal squamous cell carcinoma. It compares standard chemotherapy alone to chemotherapy plus an immunotherapy drug (cemiplimab) given before surgery. The goal is to see if adding immunotherapy helps shrink tumors more…
Matched conditions: STAGE III SINONASAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:57 UTC
-
New drug combo aims to boost radiation therapy for head and neck cancer
Disease control Recruiting nowThis early-phase trial tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe for people with advanced head and neck cancer. Ipatasertib may help stop cancer cells from growing. About 46 adults with certain types of head and neck can…
Matched conditions: STAGE III SINONASAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:56 UTC